1. Home
  2. List
Reference Patent

Reference - List

  • 69 Hits
  • Search Condition : Filter (MeSH = RANK Ligand)
Species Resource Title
Human and Animal Cells ST2(RCB0224) Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone.
Human and Animal Cells ST2(RCB0224) IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo.
Human and Animal Cells ST2(RCB0224) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
Human and Animal Cells ST2(RCB224) Increasing membrane-bound MCSF does not enhance OPGL-driven osteoclastogenesis from marrow cells.
Human and Animal Cells T3M-1 Clone2(RCB1015) , HFL-I(RCB0521) , HL60(RCB0041) Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF/TRANCE that induces osteoclast formation.
Human and Animal Cells ST2(RCB0224) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.
Human and Animal Cells MC3T3-E1(RCB1126) Effect of aging on bone metabolism: the involvement of complement C1q.
Human and Animal Cells ST2(RCB0224) IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
Human and Animal Cells MC3T3-E1(RCB1126) Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells.
Human and Animal Cells ST2(RCB0224) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Human and Animal Cells RAW 264(RCB0535) Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Human and Animal Cells RAW 264(RCB0535) Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Human and Animal Cells RAW 264(RCB0535) , ST2(RCB0224) Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
Human and Animal Cells RAW 264(RCB0535) Cardiotrophin Like Cytokine Factor 1 (CLCF1) alleviates bone loss in osteoporosis mouse models by suppressing osteoclast differentiation through activating interferon signaling and repressing the nuclear factor-κB signaling pathway.
Human and Animal Cells ST2(RCB0224) MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Human and Animal Cells ST2(RCB0224) Influence of Angptl1 on osteoclast formation and osteoblastic phenotype in mouse cells.
Human and Animal Cells RAW 264(RCB0535) Fluorinated Kavalactone Inhibited RANKL-Induced Osteoclast Differentiation of RAW264 Cells.
Human and Animal Cells HL60(RCB0041) , MC3T3-E1(RCB1126) , MC3T3-G2/PA6(RCB1127) , ST2(RCB0224) Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
Human and Animal Cells ST2(RCB0224) Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis.
Human and Animal Cells RAW 264(RCB0535) Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.